Please ensure Javascript is enabled for purposes of website accessibility
chris-preston

Chris Preston

Editor in Chief and Chief Analyst of Cabot Stock of the Week and Cabot Value Investor

Chris Preston is Cabot Wealth Network’s Vice President of Content and Chief Analyst of Cabot Stock of the Week and Cabot Value Investor .

Chris joined Cabot in 2015, where he previously served as staff analyst, web editor, and Chief Analyst of Cabot Wealth Daily, our free investment advisory, which in 2019 was named “Best Financial/Investing Newsletter or Ezine” at the SIPA (Specialized Information Publishers Association) Awards, with Chris at the helm.

Prior to joining Cabot, Chris was an analyst and assistant managing editor with Wyatt Investment Research. He has been an investment analyst for more than a decade and a professional writer/editor for nearly 20 years, picking up multiple writing awards along the way. His bylines have appeared in Forbes, The Money Show, Time Magazine, U.S. News and World Report and ESPN.com.

Chris lives in Vermont with his wife, two young kids and their golden retriever, Scout. He occasionally sleeps.

From this author
A company’s share price doesn’t always accurately reflect the value of the company, and right now, an entire subsector is being historically undervalued by the market.
Value stocks are starting to gain traction.

No, they’re still not outperforming growth stocks. But the 10.5% year-to-date gain in the Vanguard Value Index Fund (VTV) puts it on track for its best year since 2021, and potentially its third-best year in the last decade. That’s progress. And much of the progress has come this month, as the previously thin bull market rally has spread to the myriad unloved non-tech sectors. Value stocks are up more than 3% this month, outperforming growth stocks (as measured by the QQQ ETF), which are flat in July.
Volatile stocks can be exhausting to have in your portfolio. And that’s why you should avoid these three volatile stocks.
Dog days of summer? Ha!

Not in the midst of a presidential election with enough drama for an entire season of Game of Thrones, rising U.S.-China-Taiwan tensions, a software failure slowing global commerce to a halt (briefly), two major wars still ongoing, and the Olympics just four days away. It’s enough to cause investors to make rash decisions. So let’s make some sane ones instead by selling two obvious underperforming fallen tech stars and adding a low-drama dividend payer that has a long history of outperforming the market.

It’s all part of today’s busy mid-summer issue. Let’s get started.
Stock market trends last longer than anyone expects.

That was the oft-repeated adage of my former boss, Cabot legend Tim Lutts. And he was right. For all the tsk-tsking about the current bull market being long in the tooth, it’s actually tied for the shortest bull market (21 months) in history at the moment, according to data from Ryan Detrick of Carson Research Group. The average bull market lasts 61 months – nearly three times the length of the current one!
It’s only been a week. But small-cap stocks are suddenly on a tear – in stark contrast to their large-cap brethren. Does it mean an extended small-cap rally has arrived? Let’s examine.
The bull market finally expanded to more than just a select few names last week, with small caps, Chinese stocks and other sectors finally getting some love. It’s a good sign for the rally’s longevity and could be a boon for our diverse portfolio. So today, we add another non-AI, non-tech stock that’s been attracting some overdue buying. It’s a big-name, resilient growth company whose stock consistently outperforms the market – and yet is undervalued at the moment. It’s a recommendation I just shared with my Cabot Value Investor readers, and today it joins our Stock of the Week portfolio.
The FAANGs are the biggest growth stocks on the market today. What are the companies most likely to be the next FAANG stocks?
If it feels like value stocks are missing the bull market party this year, take comfort in knowing they’re not alone.

Thanks to the Magnificent Seven and a few other mega-cap tech stocks and red-hot artificial intelligence plays, the S&P 500 and the Nasdaq have posted very strong returns through the first half of 2024, up 17.6% and 24.8%, respectively. But most other indexes and funds have had very average years. The Dow is up a mere 4.2%. The Russell 2000 (small-cap stocks) is up 0.8%. And the Equal Weight S&P 500 index is up 3.7% and is well off its late-March peak.
The stock market performance under Donald Trump was strong. But history says investors favor a Democrat in the White House.
Stocks began the second half of 2024 exactly the way they behaved for much of the first half: at all-time highs, but with only a couple handfuls of mega-cap tech stocks and artificial intelligence plays doing most of the heavy lifting. It remains both a bull market and a stock picker’s market, so today we pick a stock that’s been attracting a lot of institutional attention of late. It’s a tech stock, but it’s no mega-cap; it’s a small-cap, space-related title that Tyler Laundon recommended to his Cabot Early Opportunities audience last month. Its shares have exactly doubled this year and yet still trade 40% below their 2021 highs.

Details inside.
Consumer cyclicals, perhaps more than any other sector, are at the nexus of what we look for in Cabot Value Investor these days: solid growth, but at value prices. And today we add a high-profile stock from one of the most resilient subsectors of an otherwise sluggish retail space. Its shares were overly beaten down in the weeks since underwhelming May retail sales prompted a flash mini-selloff in all things retail. But this remarkably reliable, steady-as-she-goes growth company didn’t deserve it, and shares are now trading at a rare discount.

Details inside.
With stocks at fresh highs, is a stock market top imminent? Here are five ways to know if the bull market is starting to die of old age.
After a productive but top-heavy first half of the year in the market, we set our sights on the back half of the year, and the potentially shifting winds from mega-cap tech and artificial intelligence into the many other unloved sectors. So to kick off the second half of 2024, today we add a retailer that’s bucking the trend of slowing U.S. retail sales due to its discount offerings – which plays well in an inflationary environment. It’s a new pick from Mike Cintolo in his Cabot Top Ten Trader advisory.

Details inside.
The original meme stock rally was a strange time in the market, and the fact that we’re seeing a repeat of it is stranger still. So, do we need to worry that it’ll play out in the same way and put an end to the bull market?
There’s no shortage of opinions on stock valuations these days, but instead of listening to them, pay attention to the market itself.
Bitcoin has been one of the best investments over the last five years, but is bitcoin a good long-term investment? Let’s examine.
Editor’s Note: Due to the Fourth of July holiday next Thursday, your July issue of Cabot Value Investor will come out next Friday, July 5. Happy 4th!

Leveraging cyclicality is a good way to squeeze more profits out of value stocks.

That was an idea put forth by Matt Warder, the newest addition to the Cabot analyst team and the successor to Bruce Kaser in Cabot Value Investor’s “sister” value investing advisory, Cabot Turnaround Letter, on the latest edition of the Street Check podcast I host with my colleague Brad Simmerman.
They are two of the most recognizable names out there, and good stocks, but which is the better buy? Let’s break down Apple vs. Amazon stock.
Stocks have hit the pause button in the last week. Is summer malaise already setting in? Or is this merely a deep breath before the buyers gain more fodder in the form of dovish Fed speak or the next round of earnings reports? We’ll see. In case it’s the former, today we add a value stock that potentially has an immediate, near-term catalyst. It’s the first contribution from the newest addition to our Cabot team, Matt Warder, a market veteran and cyclicals/commodities expert who has taken over our Cabot Turnaround Letter advisory. I think you’ll enjoy Matt’s unique, outside-the-box perspective.

Details inside.
Renewable energy companies and their stock prices are rarely in sync. But solar socks in particular have become grossly undervalued – and history suggests that a major bounce-back is imminent.
The market is at all-time highs. But most stocks are undervalued.

That’s the strange but true reality in today’s Magnificent 7/AI-centric bull market. Yes, if you’ve invested in the seven largest mega-caps or a handful of artificial intelligence-related stocks (Broadcom (AVGO), Palantir (PLTR), Super Micro Computer (SMCI), Taiwan Semiconductor (TSM), etc.), you’ve done quite well. But most other sectors have lagged.
Stocks keep rising to new highs, though only a handful of sectors are truly participating in the rally. That will need to change if the market is to sustain its recent momentum, but for now, we’ll go with the tides and lean into one of the new-age subsectors that’s been attracting major sponsorship: GLP-1, a.k.a. weight-loss drugs. They’re all the rage these days and have driven portfolio holdings Eli Lilly (LLY) and Novo Nordisk (NVO) to great heights. And today, we add a more under-the-radar, indirect play on the trend in the form of a mid-cap health food upstart that was recently recommended by Tyler Laundon to his Cabot Early Opportunities audience.

Details inside.
Worried that the next bear market is long overdue? This 100-year stock market chart may help provide some encouraging perspective.
Water, the most abundant resource on the planet, is becoming increasingly scarce in certain parts. These water stocks and ETFs are thriving.
Good enough.

That was the resounding sentiment on Wall Street after Wednesday morning’s inflation print came in slightly better than expectations … but still stubbornly above 3% year over year. The headline CPI number for May, 3.3% year over year, was just below the 3.4% economists anticipated; the month-over-month increase (0.2%) was also a bit lighter than expected (0.3%).
It’s another week of inflation data, Fed speak and interest rate angst, but you shouldn’t let any of it influence what stocks you’re buying and selling. Stock of the Week is a long-term stock portfolio, and one week of parsing CPI data and Jerome Powell’s words isn’t going to alter the trajectory of your best stocks. Meanwhile, the major indexes are at all-time highs, despite some under-the-surface churn. So today, we take a big swing in the form of a small-cap, Canadian-based rare earths company that’s been in Carl Delfeld’s Cabot Explorer portfolio for months.

Details inside.
In comparing Coke vs. Pepsi stock, neither soda giant will blow you away. But over the long haul, both are uncannily reliable. Which is best?
Renewable energy stocks have never lived up to their considerable promise, having peaked more than 16 years ago. And yet, there’s rarely been a bigger gap between the stocks’ value and the industry’s growth in the wake of the Inflation Reduction Act. Renewable energy projects – solar in particular – have taken off since President Biden signed that bit of eco-friendly legislation, in August 2022. Most solar companies are reporting record revenues these days. But the stocks haven’t followed suit, trading at 2018 levels.

That seems like a pretty extreme divergence between the industry and its companies’ share prices. So in this month’s issue of Cabot Value Investor, we add a solar company that’s capitalizing on the global investment in alternative energy, but is still woefully undervalued, trading at a mere 0.18x record sales.

Details inside.
Investing in a business development company is a high-risk, high-reward proposition for income investors. But you can mitigate risks.